A high SEPINA1 expression has a good prognostic value based on TCGA gene expression data in estrogen receptor (ER) + HER2 + breast cancer, not in ER- or ER + HER2- breast cancer, according to Chan et el. This evidence concerns the gene ERBB2 and breast carcinoma.